nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—appendage—amyotrophic lateral sclerosis	0.114	0.363	CbGeAlD
Pentosan Polysulfate—Prostate cancer—Riluzole—amyotrophic lateral sclerosis	0.0428	0.129	CcSEcCtD
Pentosan Polysulfate—FGF4—embryo—amyotrophic lateral sclerosis	0.0378	0.121	CbGeAlD
Pentosan Polysulfate—Subarachnoid haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0376	0.113	CcSEcCtD
Pentosan Polysulfate—FGF1—appendage—amyotrophic lateral sclerosis	0.0301	0.096	CbGeAlD
Pentosan Polysulfate—FGF1—nerve—amyotrophic lateral sclerosis	0.0213	0.0681	CbGeAlD
Pentosan Polysulfate—FGF4—nervous system—amyotrophic lateral sclerosis	0.0181	0.0579	CbGeAlD
Pentosan Polysulfate—FGF1—hindbrain—amyotrophic lateral sclerosis	0.016	0.051	CbGeAlD
Pentosan Polysulfate—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0437	CcSEcCtD
Pentosan Polysulfate—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0437	CcSEcCtD
Pentosan Polysulfate—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0321	CcSEcCtD
Pentosan Polysulfate—FGF1—embryo—amyotrophic lateral sclerosis	0.00998	0.0319	CbGeAlD
Pentosan Polysulfate—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00935	0.0282	CcSEcCtD
Pentosan Polysulfate—FGF1—brainstem—amyotrophic lateral sclerosis	0.00915	0.0292	CbGeAlD
Pentosan Polysulfate—FGF2—medulla oblongata—amyotrophic lateral sclerosis	0.00858	0.0274	CbGeAlD
Pentosan Polysulfate—FGF2—spinal cord—amyotrophic lateral sclerosis	0.00765	0.0244	CbGeAlD
Pentosan Polysulfate—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00742	0.0224	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00679	0.0205	CcSEcCtD
Pentosan Polysulfate—FGF1—medulla oblongata—amyotrophic lateral sclerosis	0.00638	0.0204	CbGeAlD
Pentosan Polysulfate—FGF2—cerebellum—amyotrophic lateral sclerosis	0.00606	0.0194	CbGeAlD
Pentosan Polysulfate—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00587	0.0177	CcSEcCtD
Pentosan Polysulfate—FGF1—spinal cord—amyotrophic lateral sclerosis	0.00569	0.0182	CbGeAlD
Pentosan Polysulfate—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00565	0.017	CcSEcCtD
Pentosan Polysulfate—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00554	0.0167	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.0055	0.0166	CcSEcCtD
Pentosan Polysulfate—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00528	0.0159	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00502	0.0151	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00494	0.0149	CcSEcCtD
Pentosan Polysulfate—FGF2—brain—amyotrophic lateral sclerosis	0.00493	0.0157	CbGeAlD
Pentosan Polysulfate—FGF1—nervous system—amyotrophic lateral sclerosis	0.00479	0.0153	CbGeAlD
Pentosan Polysulfate—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00476	0.0144	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0047	0.0142	CcSEcCtD
Pentosan Polysulfate—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00469	0.0141	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00466	0.0141	CcSEcCtD
Pentosan Polysulfate—FGF1—central nervous system—amyotrophic lateral sclerosis	0.00461	0.0147	CbGeAlD
Pentosan Polysulfate—Depression—Riluzole—amyotrophic lateral sclerosis	0.00458	0.0138	CcSEcCtD
Pentosan Polysulfate—FGF1—cerebellum—amyotrophic lateral sclerosis	0.00451	0.0144	CbGeAlD
Pentosan Polysulfate—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00448	0.0135	CcSEcCtD
Pentosan Polysulfate—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00448	0.0135	CcSEcCtD
Pentosan Polysulfate—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0044	0.0133	CcSEcCtD
Pentosan Polysulfate—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00438	0.0132	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00433	0.0131	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00431	0.013	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00413	0.0125	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0123	CcSEcCtD
Pentosan Polysulfate—FGF1—brain—amyotrophic lateral sclerosis	0.00366	0.0117	CbGeAlD
Pentosan Polysulfate—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00364	0.011	CcSEcCtD
Pentosan Polysulfate—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00354	0.0107	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00333	0.01	CcSEcCtD
Pentosan Polysulfate—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00332	0.01	CcSEcCtD
Pentosan Polysulfate—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00995	CcSEcCtD
Pentosan Polysulfate—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00977	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00969	CcSEcCtD
Pentosan Polysulfate—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00922	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00922	CcSEcCtD
Pentosan Polysulfate—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00911	CcSEcCtD
Pentosan Polysulfate—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00884	CcSEcCtD
Pentosan Polysulfate—Infection—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00878	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00865	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00854	CcSEcCtD
Pentosan Polysulfate—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00843	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00805	CcSEcCtD
Pentosan Polysulfate—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00799	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00794	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00261	0.00788	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00778	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00768	CcSEcCtD
Pentosan Polysulfate—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00756	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00728	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00723	CcSEcCtD
Pentosan Polysulfate—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00702	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00699	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00651	CcSEcCtD
Pentosan Polysulfate—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00625	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.002	0.00605	CcSEcCtD
Pentosan Polysulfate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00585	CcSEcCtD
Pentosan Polysulfate—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00562	CcSEcCtD
Pentosan Polysulfate—Rash—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00557	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00557	CcSEcCtD
Pentosan Polysulfate—Headache—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00554	CcSEcCtD
Pentosan Polysulfate—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00525	CcSEcCtD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00109	0.00306	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00109	0.00305	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—CASP9—amyotrophic lateral sclerosis	0.00107	0.00301	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—CASP9—amyotrophic lateral sclerosis	0.00106	0.00297	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—CASP9—amyotrophic lateral sclerosis	0.00105	0.00295	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	0.00105	0.00295	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—CASP9—amyotrophic lateral sclerosis	0.00104	0.00294	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—CASP9—amyotrophic lateral sclerosis	0.00104	0.00292	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00104	0.00292	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—CASP9—amyotrophic lateral sclerosis	0.00102	0.00288	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—CASP9—amyotrophic lateral sclerosis	0.00102	0.00288	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—VTA1—amyotrophic lateral sclerosis	0.00101	0.00284	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	0.00101	0.00283	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.00101	0.00283	CbGpPWpGaD
Pentosan Polysulfate—FGF1—FGF signaling pathway—MMP9—amyotrophic lateral sclerosis	0.00101	0.00283	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—ERBB4—amyotrophic lateral sclerosis	0.001	0.00282	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Differentiation Pathway—VEGFA—amyotrophic lateral sclerosis	0.000993	0.00279	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00099	0.00278	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—CASP9—amyotrophic lateral sclerosis	0.000978	0.00275	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—CASP9—amyotrophic lateral sclerosis	0.000978	0.00275	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—CASP9—amyotrophic lateral sclerosis	0.000978	0.00275	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—CASP9—amyotrophic lateral sclerosis	0.000969	0.00273	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—CASP9—amyotrophic lateral sclerosis	0.000962	0.00271	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—ERBB4—amyotrophic lateral sclerosis	0.000961	0.0027	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—CASP9—amyotrophic lateral sclerosis	0.000961	0.0027	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—CASP9—amyotrophic lateral sclerosis	0.000957	0.00269	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—CASP9—amyotrophic lateral sclerosis	0.000957	0.00269	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—CASP9—amyotrophic lateral sclerosis	0.000953	0.00268	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—CASP9—amyotrophic lateral sclerosis	0.000948	0.00267	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.000946	0.00266	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—CASP9—amyotrophic lateral sclerosis	0.000934	0.00263	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IRS-related events triggered by IGF1R—IGF1—amyotrophic lateral sclerosis	0.000928	0.00261	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00092	0.00259	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—ERBB4—amyotrophic lateral sclerosis	0.000916	0.00258	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—ATF1—amyotrophic lateral sclerosis	0.00091	0.00256	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Differentiation Pathway—VEGFA—amyotrophic lateral sclerosis	0.000905	0.00255	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—CASP9—amyotrophic lateral sclerosis	0.000905	0.00255	CbGpPWpGaD
Pentosan Polysulfate—FGF1—IGF1R signaling cascade—IGF1—amyotrophic lateral sclerosis	0.000903	0.00254	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—ERBB4—amyotrophic lateral sclerosis	0.000903	0.00254	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—ERBB4—amyotrophic lateral sclerosis	0.000899	0.00253	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	0.000898	0.00253	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—ERBB4—amyotrophic lateral sclerosis	0.000894	0.00251	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—CASP9—amyotrophic lateral sclerosis	0.000892	0.00251	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—CASP9—amyotrophic lateral sclerosis	0.000892	0.00251	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—CASP9—amyotrophic lateral sclerosis	0.000892	0.00251	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—ERBB4—amyotrophic lateral sclerosis	0.00089	0.0025	CbGpPWpGaD
Pentosan Polysulfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—IGF1—amyotrophic lateral sclerosis	0.000886	0.00249	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—CASP9—amyotrophic lateral sclerosis	0.000884	0.00249	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—ERBB4—amyotrophic lateral sclerosis	0.000877	0.00247	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—ERBB4—amyotrophic lateral sclerosis	0.000876	0.00246	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—CASP9—amyotrophic lateral sclerosis	0.000876	0.00246	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—CASP9—amyotrophic lateral sclerosis	0.000872	0.00245	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—CASP9—amyotrophic lateral sclerosis	0.000866	0.00244	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.000862	0.00243	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IRS-related events triggered by IGF1R—IGF1—amyotrophic lateral sclerosis	0.000846	0.00238	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000839	0.00236	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—ERBB4—amyotrophic lateral sclerosis	0.000837	0.00235	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—ERBB4—amyotrophic lateral sclerosis	0.000837	0.00235	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—ERBB4—amyotrophic lateral sclerosis	0.000837	0.00235	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—ERBB4—amyotrophic lateral sclerosis	0.00083	0.00233	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—ATF1—amyotrophic lateral sclerosis	0.000829	0.00233	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—CASP9—amyotrophic lateral sclerosis	0.000825	0.00232	CbGpPWpGaD
Pentosan Polysulfate—FGF2—IGF1R signaling cascade—IGF1—amyotrophic lateral sclerosis	0.000824	0.00232	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—ERBB4—amyotrophic lateral sclerosis	0.000824	0.00232	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—ERBB4—amyotrophic lateral sclerosis	0.000822	0.00231	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—ERBB4—amyotrophic lateral sclerosis	0.000819	0.0023	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—ERBB4—amyotrophic lateral sclerosis	0.000819	0.0023	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—ERBB4—amyotrophic lateral sclerosis	0.000815	0.00229	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—ERBB4—amyotrophic lateral sclerosis	0.000811	0.00228	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TPK1—amyotrophic lateral sclerosis	0.000802	0.00226	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Endochondral Ossification—MMP9—amyotrophic lateral sclerosis	0.000801	0.00225	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—ERBB4—amyotrophic lateral sclerosis	0.0008	0.00225	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—CASP9—amyotrophic lateral sclerosis	0.00079	0.00222	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000776	0.00218	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—ERBB4—amyotrophic lateral sclerosis	0.000775	0.00218	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000765	0.00215	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—ERBB4—amyotrophic lateral sclerosis	0.000763	0.00215	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—ERBB4—amyotrophic lateral sclerosis	0.000763	0.00215	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—ERBB4—amyotrophic lateral sclerosis	0.000763	0.00215	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—ERBB4—amyotrophic lateral sclerosis	0.000757	0.00213	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—ERBB4—amyotrophic lateral sclerosis	0.00075	0.00211	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—ERBB4—amyotrophic lateral sclerosis	0.000747	0.0021	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—SQSTM1—amyotrophic lateral sclerosis	0.000746	0.0021	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—ERBB4—amyotrophic lateral sclerosis	0.000741	0.00209	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000741	0.00208	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	0.000736	0.00207	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TPK1—amyotrophic lateral sclerosis	0.000731	0.00206	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrins in angiogenesis—VEGFA—amyotrophic lateral sclerosis	0.000728	0.00205	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000728	0.00205	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Endochondral Ossification—VEGFA—amyotrophic lateral sclerosis	0.000719	0.00202	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000707	0.00199	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—ERBB4—amyotrophic lateral sclerosis	0.000707	0.00199	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	0.0007	0.00197	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PLB1—amyotrophic lateral sclerosis	0.000692	0.00195	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—SQSTM1—amyotrophic lateral sclerosis	0.00068	0.00191	CbGpPWpGaD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000677	0.0019	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—ERBB4—amyotrophic lateral sclerosis	0.000676	0.0019	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000675	0.0019	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	0.000666	0.00187	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000658	0.00185	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—VTA1—amyotrophic lateral sclerosis	0.000641	0.0018	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	0.00064	0.0018	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	0.000638	0.00179	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000629	0.00177	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—VCP—amyotrophic lateral sclerosis	0.000617	0.00174	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000611	0.00172	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	0.000608	0.00171	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.0006	0.00169	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000599	0.00168	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—VTA1—amyotrophic lateral sclerosis	0.000585	0.00164	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	0.000583	0.00164	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.000575	0.00162	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	0.00057	0.0016	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	0.00052	0.00146	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000512	0.00144	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000504	0.00142	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000492	0.00138	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000486	0.00137	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000485	0.00136	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	0.000467	0.00131	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000463	0.0013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000459	0.00129	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000456	0.00128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000443	0.00125	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CST3—amyotrophic lateral sclerosis	0.000443	0.00125	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000442	0.00124	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PLB1—amyotrophic lateral sclerosis	0.000439	0.00124	CbGpPWpGaD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.000434	0.00122	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000432	0.00122	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000426	0.0012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	0.000426	0.0012	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000418	0.00118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000418	0.00117	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000409	0.00115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PLB1—amyotrophic lateral sclerosis	0.000401	0.00113	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000399	0.00112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—VCP—amyotrophic lateral sclerosis	0.000392	0.0011	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.00039	0.0011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000388	0.00109	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000388	0.00109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000381	0.00107	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.00038	0.00107	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000372	0.00104	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000367	0.00103	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—ATF1—amyotrophic lateral sclerosis	0.000366	0.00103	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.000365	0.00103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000364	0.00102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—VCP—amyotrophic lateral sclerosis	0.000357	0.001	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000354	0.000995	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000353	0.000994	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CASP9—amyotrophic lateral sclerosis	0.000349	0.000981	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000347	0.000975	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.000333	0.000936	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000329	0.000925	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000325	0.000915	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CASP9—amyotrophic lateral sclerosis	0.000322	0.000906	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000312	0.000878	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000308	0.000865	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.0003	0.000844	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000298	0.000839	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000297	0.000834	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000294	0.000826	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000289	0.000814	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000285	0.000801	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CST3—amyotrophic lateral sclerosis	0.000281	0.00079	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000281	0.000789	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000281	0.000789	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000281	0.000789	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—ERBB4—amyotrophic lateral sclerosis	0.000276	0.000775	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000274	0.000771	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—CASP3—amyotrophic lateral sclerosis	0.000273	0.000767	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—C3—amyotrophic lateral sclerosis	0.00027	0.00076	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000268	0.000753	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000266	0.000747	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000264	0.000742	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.00026	0.00073	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—MMP9—amyotrophic lateral sclerosis	0.000258	0.000725	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CST3—amyotrophic lateral sclerosis	0.000256	0.000721	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000256	0.00072	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000252	0.00071	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00025	0.000703	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000249	0.000699	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—C3—amyotrophic lateral sclerosis	0.000248	0.000698	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000248	0.000697	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000246	0.000693	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000242	0.000681	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000237	0.000666	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000237	0.000666	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000236	0.000663	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000233	0.000656	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ATF1—amyotrophic lateral sclerosis	0.000232	0.000654	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000227	0.000637	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000226	0.000636	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000225	0.000634	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CASP9—amyotrophic lateral sclerosis	0.000221	0.000623	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000215	0.000605	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—APOE—amyotrophic lateral sclerosis	0.000213	0.0006	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000213	0.000598	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ATF1—amyotrophic lateral sclerosis	0.000212	0.000596	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CASP9—amyotrophic lateral sclerosis	0.000204	0.000575	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CASP9—amyotrophic lateral sclerosis	0.000202	0.000568	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000193	0.000543	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000189	0.000533	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CASP9—amyotrophic lateral sclerosis	0.000186	0.000524	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000181	0.00051	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000178	0.000501	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB4—amyotrophic lateral sclerosis	0.000175	0.000492	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000173	0.000486	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000162	0.000457	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00016	0.000451	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00016	0.000451	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB4—amyotrophic lateral sclerosis	0.00016	0.000449	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—C3—amyotrophic lateral sclerosis	0.000157	0.000443	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000156	0.000439	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00015	0.000423	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000149	0.00042	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000146	0.000411	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTGS2—amyotrophic lateral sclerosis	0.000146	0.000411	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—C3—amyotrophic lateral sclerosis	0.000144	0.000404	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000143	0.000402	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.00014	0.000394	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000137	0.000385	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APOE—amyotrophic lateral sclerosis	0.000135	0.000381	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000131	0.000367	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APOE—amyotrophic lateral sclerosis	0.000123	0.000347	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000123	0.000347	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000122	0.000344	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000115	0.000324	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000112	0.000314	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000105	0.000295	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000102	0.000286	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.49e-05	0.000267	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.48e-05	0.000266	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.28e-05	0.000261	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—amyotrophic lateral sclerosis	9.27e-05	0.000261	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.97e-05	0.000252	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.64e-05	0.000243	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—amyotrophic lateral sclerosis	8.45e-05	0.000238	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.06e-05	0.000227	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.83e-05	0.00022	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.14e-05	0.000201	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.09e-05	0.000171	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.03e-05	0.00017	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.7e-05	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.5e-05	0.000155	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.19e-05	0.000146	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.11e-05	0.000144	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.66e-05	0.000131	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.86e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.52e-05	9.91e-05	CbGpPWpGaD
